Jeffrey G Spragens is of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 394,989 shares of SABS, which is worth approximately $1.6 Million. The most recent transaction as insider was on Dec 07, 2022, when has been sold 82,987 shares (Common Stock) at a price of $1.21 per share, resulting in proceeds of $100,414. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 395K
0% 3M change
0% 12M change
Total Value Held $1.6 Million

Jeffrey G Spragens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2022
BUY
Grant, award, or other acquisition
$100,414 $1.21 p/Share
82,987 Added 17.36%
394,989 Common Stock
May 20 2022
BUY
Other acquisition or disposition
-
299,002 Added 48.94%
312,002 Common Stock
Oct 01 2021
BUY
Open market or private purchase
$130,910 $10.07 p/Share
13,000 Added 50.0%
13,000 Common Stock
JGS

Jeffrey G Spragens

Miami Beach, FL

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Track Activities on SABS